Akute Rhythmusstörungen

Zusammenfassung

Jede Abweichung vom normalen Sinusrhythmus ist eine Rhythmusstörung. Bradykarde werden von tachykarden, stabile von instabilen Rhythmusstörungen unterschieden. Die Therapie folgt standardisierten Algorithmen. Stabile Rhythmusstörungen werden medikamentös, instabile elektrisch behandelt.

Abstract

Any aberration from sinus rhythm is an arrhythmia. Bradycardias differ from tachycardias, stable cardiac arrhythmias are different from unstable forms. Therapy follows standardized algorithms. Stable arrhythmias are treated with drugs, unstable electrical.

Schlüsselwörter

akute Rhythmusstörungen - Diagnostik - Bradykardie - Tachykardie - Therapie

Keywords

acute arrhythmias - diagnosis - bradycardia - tachycardia - therapy

Literatur

• 1 Allessie M A, Bonke F IM, Schopman F JG. Circus movement in the rabbit atrial muscle as a mechanism of tachycardia II. The role of non-uniform recovery of excitability in the occurrence on unidirectional block as studied with multiple electrodes.  Circ Res. 1976;  39 168-177
• 2 Andersen R H, Becker A E, Brechenacher C et al. The human atrioventricular area: a morphologic study of the AV node and bundle.  Europ J Card. 1975;  8 11-25
• 3 Anselm F, Hook B, Monahan K. Heterogenity of retrograde fastpathway conduction pattern in patients with atrioventricular nodal reentry tachycardia: observations by use of simultaneous multisite catheter mapping of Kochs’ triangle.  Circulation. 1996;  93 960-968
• 4 Bennett D H. Cardiac Arrhythmias.. London: Hodder Arnold; 2006
• 5 Braunwald E, Libby P, Bonow R O, Mann D L, Zipes D P Hrsg. Braunwald’s Heart Disease.. Philadelphia: Saunders Elsevier; 2008
• 6 Brugada P, Brugada J, Mont L et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex.  Circulation. 1991;  69 1649-1659
• 7 CAST Investigators . Preliminary report, effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.  New Engl J Med. 1898;  321 406-412
• 8 CAST II. Effect of antiarrhythmic agent moricizine on survival after myocardial infarction.  New Engl J Med. 1992;  327 227-233
• 9 Conti J B, Curtis A B. Adenosine: Use as a diagnostic and therapeutic tool.  Card Electrophysiol Rev. 2000;  4 227-232
• 10 Deakin C D, Sado D, Petley G et al. Determing the optimal paddle force for external defibrillation.  Am J Cardiol. 2002;  90 812-813
• 11 Deakin C D, Nolan J P. European Resuscitation Council Guidelines for Resuscitation 2010, Section 3: Electrical therapies: Automated external defibrillators, defibrillation, cardioversion and pacing.  Resuscitation. 2010;  81 1293-1304
• 12 Deakin C D, Nolan J P, Soar J et al. European Resuscitation Council Guidelines for Resuscitation 2010a. Section 4: Adult advanced life support.  Resuscitation. 2010;  81 1305-1352
• 13 DiMarco J P, Sellers T D, Lerman B B et al. Diagnostic and therapeutic use of adenosine in patients with supraventrikular tachyarrhythmias.  J Am Coll Cardiol. 1985;  6 417-425
• 14 Erdmann E Hrsg. Klinische Kardiologie.. Berlin, Heidelberg, New York: Springer; 2009
• 15 El-Sherif N, Boutjdir M, Gough W B. Early afterdepolarisations and arrhythmogenesis.  J Cardiovasc Electrophysiol. 1990;  1 145-160
• 16 Haverkamp W, Breithart G. Moderne Herzrhythmustherapie.. Stuttgart: Georg Thieme; 2003
• 17 Heuer H, Krämer L I. Therapie bradykarder Rhythmusstörungen.. In: Griebenow R, Gülker H, Hrsg Autonomes Nervensystem und Herzrhythmusstörungen.. Stuttgart: Georg Thieme; 1990: 213-235
• 18 Koster R W, Dorian P, Chapman F W et al. A randomized trial comparing monophasic and biphasic waveform shocks for external defibrillation of atrial fibrillation.  Am Heart J. 2004;  147 e20
• 19 Lüderitz B. Therapie der Herzrhythmusstörungen.. Berlin: Springer; 2000
• 20 Nattel S. New ideas about atrial fibrillation 50 years on.  Nature. 2002;  415 219-226
• 21 Newman D. Overview of Lidocaine.  Card Electrophysiol Rev. 2000;  4 248-250
• 22 Rubart M, Zipes D P. Genesis of cardiac arrythmias: electrophysiological considerations.. In: Zipes D P, Libby P, Bonow R O, Braunwald E, Hrsg Braunwald’s Heart Disease. A textbook of cardiovascular medicine.. Philadelphia: Elsevier Saunders; 2005: 653-919
• 23 Sager P T. Investigational class III antiarrhythmic agents.  Cardiac Electrophysiol Rev. 2000;  4 320-326
• 24 Saoudi N, Cosio F, Waldo A. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic base: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacin and Electrophysiology.  J CardiovascElectrophysiol. 2001;  12 852-866
• 25 Scherf D, Schott A. Extrasystoles and allied arrhythmias.. New York: Grune & Stratton; 1953
• 26 Stambler B S. Update on intravenous Ibutilide.  Cardiac Electophysiol Rev. 2000;  4 2743-2747
• 27 Stanton M. Class I antiarrhythmic drugs: quinidine, procainamide, disopyramide, lidocaine, mexiletine, tocainide, phytoin, morizine, flecainide, propafenone.. In: Zipes D P, Jalif J, Hrsg Cardiac electrophysiology. From cell to bedside.. 3. Aufl. Philadelphia: WB Saunders; 2000: 890-903
• 28 Stults K R, Brown D D, Cooley F et al. Self-adhesive monitor / defibrillation pads improve prehospital defibrillation success.  Ann Emerg Med. 1987;  16 872-877
• 29 Task force of the Working Group on Arrhythmias of the European Society of Cardiology . The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms.  Circulation. 1991;  84 1831-1851
• 30 Vaughan-Williams E M. Classification of antiarrhythmic drugs.. In: Sandoe E, Flensted-Jensen E, Olsen K H, Hrsg Cardiac arrhythmias Astra.. Sondertalje Sweden; 1979: 449-472
• 31 Windecker S, Kay G N, Epstein A E. et al . Atrial flutter.  Cardiac Electrophysiology Review. 1997;  1 52-60
• 32 Zerkowski H R, Baumann G. HerzAkutMedizin.. Darmstadt: Steinkopff; 2006